Vermillion to Request Hearing with Nasdaq Panel on Continued Listing; Shares Plummet | GenomeWeb
NEW YORK (GenomeWeb News) – Vermillion said yesterday that it would request a hearing before a Nasdaq panel after it was notified by the stock exchange that it is in non-compliance with a requirement for continued listing.
 
The firm's shares fell sharply in Tuesday afternoon trade in response to the news.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.